PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 78: Articles 38501-39000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. The Jamaican male and family planning.
  2. Japan: family planning in industry.
  3. Jaundice and oral contraceptives.
  4. K.A.P. survey: a study of knowledge, attitude and practice of contraception in the Trust Territory of the Pacific Islands 1970.
  5. Knowledge and approval of family planning as correlated to some characteristics of rural respondents.
  6. Knowledge, attitudes, and practice (KAP) regarding contraception and abortion, from survey data: Hungarian experiences.
  7. Korea/Taiwan 1970: report on the national family planning programs.
  8. Korea/Taiwan: report on the national family planning programs.
  9. The Korean 1968 Fertility and Family Planning Survey. (Abstract only)
  10. Latin America and family planning.
  11. Latin American attitudes on birth control: a typology.
  12. The law and birth control, sterilization, and abortion.
  13. Law and family planning.
  14. The leader in family planning and the two-step flow model.
  15. Legal aspects of family planning in Indonesia.
  16. The legalizing of contraceptives and abortions.
  17. Leukocyte alkaline phosphatase activity in symptomatic users of intrauterine contraceptive devices.
  18. Lipoprotein lipase and postheparin esterase activity and postheparin increase in free fatty acids after the short-term administration of a sequential contraceptive.
  19. Liver function and contraceptive steroids. Evaluation of patients after more than 50 treatment cycles. [Funcion hepatica y esteroides anticonceptivos. Valoracion de pacientes con mas de 50 ciclos de tratamiento.]
  20. Liver function tests in women taking oral contraceptives.
  21. Localization of acute deep venous thrombosis in women taking oral contraceptives.
  22. Long acting injectable - Depo Provera as a contraceptive.
  23. Long acting polydimethylsiloxane implants for contraception.
  24. Long-acting injectable contraceptives.
  25. A long-term study of regression of precancerous lesions under oral progestin medication: observations on the prevalence of carcinoma in situ and dysplasia in private versus planned parenthood groups.
  26. Longitudinal study of oral contraceptive acceptors.
  27. Louisiana family planning.
  28. Louisiana: developing and managing a statewide family planning program.
  29. Low dose of gestagen as a contraceptive method.
  30. Mail-order as a vehicle for family planning delivery.
  31. Major federal resources for family planning and population research programs: a summary.
  32. Male attitudes to family planning education in Santiago, Chile.
  33. Male attitudes toward family planning: a preliminary survey.
  34. Male role in contraception.
  35. Management of family planning--policy and perspective.
  36. Manual of procedures. (Family planning research program)
  37. The marketing component of family planning.
  38. Marketing plan - a background to the commercial distribution of non-prescription contraceptives.
  39. Mass communications and field workers in family planning programs [draft]
  40. Mass motivation campaign on family planning through radio.
  41. A master plan for the delivery of family planning services to residents of Kern County, California.
  42. Maternal folate deficiency and pregnancy wastage. 4. Effects of folic acid supplements, anticonvulsants, and oral contraceptives.
  43. Mathematical models for decision making in population and family planning: a reply to Dr. Reinke.
  44. Mathematical models for decision-making in population and family planning.
  45. Mathematical models for decision-making in population and family planning.
  46. A mathematical programming model for planning contraceptive deliveries.
  47. The measurement of costs and benefits of different methods of family planning.
  48. Mechanism of action of hormonal contraception. [Wirkungsmechanismen der hormonalen Kontrazeption.]
  49. The mechanism of action of the intrauterine contraceptive device.
  50. Medical aspects of diabetes in pregnancy and the diabetogenic effects of oral contraceptives.
  51. Medical, legal, and social implications of contraceptives for teenagers.
  52. The medication monitor for studying the self-administration of oral contraceptives.
  53. Medroxyprogesterone acetate as an injectable female contraceptive.
  54. Megaloblastic anemia cause by oral contraceptives. [Megaloblastisk anemi orsakad av orala kontraseptiva.]
  55. Megaloblastic anemia due to folic acid deficiency in a young woman on oral contraceptives.
  56. Mental disability as a basis for contraception and sterilization.
  57. Mental health and family planning.
  58. Metabolic aspects after administration of oral contraceptives.) (Abstract only. [Aspects metaboliques consecutifs a l'administration de contraceptifs estroprogestatifs par voie orale.]
  59. Metabolic effects of contraceptive steroids with special reference to the lipid metabolism.
  60. Metabolism of contraceptive steroids in man.
  61. Methods for estimating future caseloads of family planning programs.
  62. Mexico City: A clinic dropout study (in family planning)
  63. The midwife in family planning. 1. In Ghana.
  64. The midwife in family planning. 2. In Thailand.
  65. Misconceptions concerning contraception.
  66. Mitotic indices and oral contraceptives.
  67. Mobile units in family planning.
  68. The mode of action of cyclic AMP as a contraceptive.
  69. Modern contraception, 2nd edition.
  70. More family planning dollars?
  71. Morning-after pill: postcoital contraception. [Morning-after-pill: Die postkoitale hormonelle Schwangerschaftsverhutung.]
  72. Motivational factors affecting contraceptive use.
  73. Multiagency participation in family planning administration.
  74. Multiple breast fibroadenomas in women on hormonal contraceptives.
  75. Myocardial infarction after contraceptive drugs (report of a case)
  76. Myocardial infarction and oral contraceptive agents.
  77. National experiences with natural family planning--England.
  78. National health insurance and family planning.
  79. Natural contraceptive biologic foam.
  80. Nervousness and depression attributed to oral contraceptives: a double--blind, placebo--controlled study.
  81. A new approach: market research in the service of family planning.
  82. New developments in contraceptive agents.
  83. A new intrauterine contraceptive loop. [Ett nytt intrauterint preventivmedel.]
  84. A new low-dosage combined oral contraceptive (Minilyn): an appraisal.
  85. A new method for estimating the level of natural fertility in populations practicing birth control.
  86. New method of birth control being tested by U.S. and Mexican women.
  87. New method of birth control: advertising.
  88. Niazbeg survey: the impact of motivational campaign family planning knowledge, attitudes, and practices.
  89. Non-medical aspects of family planning in industry.
  90. The non-Roman view (on birth control)
  91. Nonsurgical contraceptive methods for women. [Methodes contraceptives non chirurgicales chez la femme.]
  92. The Nurse's role in family planning.
  93. Observations on abortion and family planning in the Soviet Union. Notes on a 1970 visit to Moscow.
  94. Observations on needed research in family planning from the perspective of an administrator.
  95. Observations on the degree of commitment to family planning in a Calcutta City project.
  96. Occurrence of cervical carcinoma in the use of intrauterine contraception. [Pripomienky k vyskytu karcinomu cervixu pri intrauterinnej antikoncepcii.]
  97. Oestrogen/progestogen oral contraception and blood clotting: a long-term follow-up.
  98. Of grass, okra, and elephants; of cabbages and kings. (Contraceptive methods)
  99. On the mechanism of action of oral contraceptives: 1. Effect of lynestrenol on ovum implantation and oviductal morphology in the rat.
  100. On the way to a more physiological hormonal contraception.
  101. Operational problems and management of a country-wide family planning program.
  102. Operations during treatment with hormonal contraceptives. [Operationen unter hormonalen Kontrazeptiva.]
  103. Opinion of Islam on family planning.
  104. Opinion survey on family planning in rural areas. [Enquete d'opinion sur la planification familiale milieu rurale.]
  105. Opinion, ideology and population problems: some sources of domestic and foreign opposition to birth control.
  106. Or al contraceptives and thromboembolism---experiences in North America. [Orale Kontrazeptiva und Thromboembolie. Erfahrungen in Nordamerika.]
  107. Oral contraception and dermatology. [Contraception hormonale et dermatologie.]
  108. Oral contraception and platelet aggregation.
  109. Oral contraception and thromboembolic deaths. a forensic autopsy material. [Oral antikonception og tromboemboliske dodsfald. Et retsmedicinsk objuktionsmarteriale.]
  110. Oral contraception as a technique of fertility control.
  111. Oral contraception with estrogen and progestin combinations.
  112. Oral contraception. [La contraception orale.]
  113. Oral contraception. [Oral antikonception.]
  114. Oral contraception: a review of reported physiological and pathological effects.
  115. Oral contraceptive agents and the glucose tolerance problem.
  116. Oral contraceptive and skin peeling effects. [Orale Kontrazeption und Peeling-Effekt.]
  117. The oral contraceptive controversy.
  118. The oral contraceptive Norinyl-1 in porphyria.
  119. Oral contraceptive side-effects and allergy: an immune aetiology?
  120. Oral contraceptive steroids: effects on oral tolerance tests of glucose, galactose, fructose and ribose.
  121. Oral contraceptive therapy for differentiating ovarian cysts.
  122. Oral contraceptive use in U.S. shows significant rise.
  123. Oral contraceptives -- a continuing reappraisal.
  124. Oral contraceptives after liver disease.
  125. Oral contraceptives and antithrombin-III. [P-piller og antitrombin-III.]
  126. Oral contraceptives and blood pressure. Preliminary results of 3000 cases. [Contraceptifs oraux et tension arterielle. Resultats preliminaires sur 3000 cas.]
  127. Oral contraceptives and cerebral arterial occlusion. (Letter to the editor)
  128. Oral contraceptives and damage to the central nervous system. [Orale Antikonzeptionsmittel und Schadigungen des Zentralnervensystems.]
  129. Oral contraceptives and epilepsy. [P-piller og epilepsi.]
  130. Oral contraceptives and hematological data. [P-piller og hematologiske data.]
  131. Oral contraceptives and high blood pressure.
  132. Oral contraceptives and pathologic changes in the breast.
  133. Oral contraceptives and psychiatric illness.
  134. Oral contraceptives and serum copper concentration.
  135. Oral contraceptives and severe hypertension.
  136. Oral contraceptives and the skin.
  137. Oral contraceptives and thromboembolic disease.
  138. Oral contraceptives and thromboembolic disease: Swedish experience.
  139. Oral contraceptives and thromboembolism: a further report.
  140. Oral contraceptives and thyroid function tests: the diagnosis of thyroid disease.
  141. Oral contraceptives and untoward effects coincident with their use: a review.
  142. Oral contraceptives and Vitamin B6 metabolism.
  143. Oral contraceptives in haemophilia.
  144. Oral contraceptives may tend to protect against benign breast cancer.
  145. Oral contraceptives, depression, and libido.
  146. Oral contraceptives, depression, and libido.
  147. Oral contraceptives, personality, and changes in depression.
  148. (Oral contraceptives, side effects)
  149. Oral contraceptives, venous thromboembolic disease, and ABO blood type.
  150. Oral contraceptives.
  151. The oral contraceptives.
  152. Oral contraceptives.
  153. Oral contraceptives: a review.
  154. Oral contraceptives: epidemiologic problems (The chairman's summary of a conference)
  155. Oral side effects of oral contraceptives. [Manifestazioni orali degli anticoncezionali per uso orale.]
  156. Out-of-school education and family planning.
  157. Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
  158. The ovarian response to gonadotrophins after administration of an oral contraceptive.
  159. Ovariostatic effect of psychotropic drugs: Initiation to a new contraceptive method. [L'effet ovariostatique des psychotropes: Initiation a une nouvelle methode contraceptive.]
  160. Over three lakhs visit FPAI (Family Planning Association of India) exhibition.
  161. Overview of the medical and clinical activities performed by the family planning associations of the western hemisphere region.
  162. Overview: a five year plan for population research and family planning services.
  163. P.L. 91-572, milestone U.S. family planning legislation signed into law.
  164. Pakistan's national cooperative study of intrauterine contraception, 1962-68.
  165. Panchayat members and family planning.
  166. Panchayat members and family planning. (Paper presented at the 14th Annual Conference of the Indian Public Health Association held in Jamshedpur, March 13-15, 1970.)
  167. Panel discussion (family planning)
  168. Panel discussion. (Family planning)
  169. Patient satisfaction vs. expectation fulfillment in a family planning service.
  170. Pattern of mating behaviour, emigration and contraceptives as factors affecting human fertility in Barbados.
  171. Patterns and purposes of oral contraceptive use by economic status.
  172. Patterns of abortion and contraceptive usage.
  173. Peptic ulceration and the use of oral contraceptives--a negative correlation attributable to the disease?
  174. Pharmacokinetics of contraceptive steroids.
  175. Pharmacology of hormonal contraception.
  176. Philippine family planning chartbook: 1971.
  177. The Philippines: family planning acceptors, January - June 1970.
  178. Photosensitivity caused by oral contraceptives.
  179. Physicians and contraception: a study of perceptions and practices in an urban southeastern United States community.
  180. The pill and the poor. Government's efforts to push birth control in the U.S. are increasing.
  181. Pill versus IUD: continuation rates of oral contraceptive and Dalkon shield users in Maryland clinics.
  182. The pill: truth and falsehoods with respect to oral contraceptives. [La pildora: realidades y falacias respecto a los actuales anticonceptivos orales.]
  183. The place and timing of contraception and sterilization.
  184. A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives.
  185. A plan for development of a coordinated family planning program in the San Francisco Bay Area.
  186. Plan of action for pilot project: comprehensive family planning program in Khuzestan Ostan.
  187. Planned Parenthood 40 years in Alabama.
  188. Planned parenthood: profile and prospectus.
  189. Planning family planning in 8 metropolitan areas.
  190. Planning today: 2 Oral contraceptives.
  191. Plasma factor IX levels and oral contraception.
  192. Plasma LH and FSH concentrations in women during and after interruption of contraceptive treatment.
  193. Plasma lipid levels after 12-24 months oral administration of contraceptives. [Plasmalipide nach 12-24monatiger oraler Gabe von Ovulationshemmer.]
  194. Plasma triglyceride turnover during use of oral contraceptives.
  195. Platelet adhesiveness in symptomatic women taking oral contraceptives.
  196. Platelet aggregation in hormonal contraception. [Plaettchen-Aggregation unter hormonalen Kontrazeptiva.]
  197. Politics, development strategy, and family planning programs in India and Pakistan.
  198. Polydimethylsiloxane implants as contraceptive devices. (Abstract only)
  199. Polypous endocervical polyadenama in a woman taking an oral contraceptive. [Polyadenome polypeux endo-cervical chez une femme prenant un contraceptif oral.]
  200. Population 70. Family Planning and Social Change. (Proceedings of the Second Conference of the Western Pacific Region of the International Planned Parenthood Federation, Tokyo, 13-16 October 1970.)
  201. Population and family planning in Iran.
  202. Population and family planning manpower and training.
  203. The position of tubal ligation in family planning.
  204. The position of tubal ligation in family planning. (Letter to the editor)
  205. Possibilities and impossibilities of production, marketing and distribution of oral contraceptives in developing countries.
  206. Possibility of immunological approach for family planning.

     

  207. The possibility of infection after the insertion of intrauterine contraceptives. [O vozmozhnosti infektsionnykh oslozhnenii posle vvedeniya vnutrimatochnykh kontratseptivov.]
  208. Postcoital contraception with diethylstilbestrol.
  209. The postpartum approach to family planning. Experiences in Thailand, 1966-1971.
  210. Postpartum family planning counseling in the clinic. [Postportale Familienplanungs-Beratung in der Klinik.]
  211. Postpartum services in family planning: findings to date.
  212. The practitioner and contraception. [Le praticien devant la contraception.]
  213. Pregnancies during oral contraceptive treatment.
  214. Pregnancy and progeny after hormonal contraceptives - genetic studies.
  215. Pregnancy outcome following oral contraceptives.
  216. A preliminary cost analysis of the family planning program in Thailand, 1968-1971.
  217. Preliminary report on a new method of mass screening by colposcopy for early detection of cancer of the cervix in a New York City family planning center.
  218. A preliminary report on the acceptability of a continuous low-dose progestogen as a form of contraception in a rural community.
  219. Prescribing of oral contraceptives to minors.
  220. Prescribing of oral contraceptives to minors.
  221. Prescribing of oral contraceptives to minors.
  222. Prescribing of oral contraceptives to minors.
  223. Prescribing of oral contraceptives to minors. (Letter to the editor)
  224. Prescribing of oral contraceptives to minors. (Letter to the editor)
  225. Prescribing of oral contraceptives to minors. (Letter to the editor)
  226. Prescribing of oral contraceptives to minors. (Letter to the editor)
  227. Prescribing of oral contraceptives to minors. (Letter to the editor)
  228. Prescribing of oral contraceptives to minors. (Letter to the editor)
  229. Present situation of family planning in Latin America 1968.
  230. The present state of family planning programs.
  231. Present status and future plans on the use of contraceptives in India.
  232. The present status of contraception.
  233. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
  234. Prevalence and effectiveness of family planning (Comment)
  235. Prevalence and effectiveness of family planning.
  236. Principles of family planning for Roman Catholics.
  237. Principles of oral contraception. 2. Side effects of oral contraceptives.
  238. Principles of oral contraception. [Grundlagen der hormonalen Kontrazeption.]
  239. Principles of oral contraception: I. mode of action of oral contraceptives.
  240. Private practitioner acceptance of the IUD; and the IUD related to other contraceptives.
  241. The private sector and family planning (summary)
  242. Problems associated with the distribution and marketing of contraceptives.
  243. Problems in contraception.
  244. Problems with contraception in adolescents: the successful use of an intrauterine device.
  245. The production and distribution of contraceptives in Colombia.
  246. Production and distribution of contraceptives in Japan.
  247. Production of family planning and population information and education resources materials.
  248. Production, distribution and use of oral contraceptives in Latin America.
  249. Progestagen-only contraception.
  250. Program plan for population and family planning during 1971-1976.
  251. Progress--but not enough: Five years of family planning in Asia.
  252. Project report: a community model for initiating and continuing education in family planning.
  253. Prolonged amenorrhea after use of oral contraceptives.
  254. Prolonged-action contraceptive and carbohydrate metabolism. [Anticonceptivo de deposito y metabolismo glucido.]
  255. Promiscuity and oral contraception: the relationship examined.
  256. Proposal for a universities group for contraceptive research made to U.S. Agency for International Development.
  257. Proposed new means test for family planning services draws wide protests.
  258. Prospects for future developments in contraception.
  259. Prospects of contraceptive research and its sequels. [Perspektivy vyskumu antikoncepcie a jej nasledkov.]
  260. Prostaglandins in family planning strategy.
  261. Psychiatric aspects of contraception.
  262. A psychological approach to the prediction of contraceptive behavior.
  263. Psychological factors in the acceptance and use of oral contraceptives.
  264. Psychological problems of contraception. [Problemes psychologiques de la contraception.]
  265. Psychological reflections on marital love and contraception.
  266. Report on the study of the impact of literacy and education on fertility and family planning.
  267. Report to the government of Iran on the incorporation of family planning care within the medical services of the social insurance organisation.
  268. Report to the government of Iran on the incorporation of family planning care within the medical services of the social insurance organization.
  269. Report to the Government of the Arab Republic of Egypt on approaches to an intensive family planning programme for the organized sector.
  270. Reported adverse effects of oral contraceptives on the eye.
  271. Research in contraception and reproduction: a status report, 1971.
  272. Research on health aspects of contraceptive agents.
  273. Resources available in East Africa for conducting family planning research.
  274. Results of a trial of a new intrauterine contraceptive device.
  275. Results of a trial of a new intrauterine contraceptive device. (Letter to the editor)
  276. Results of an investigation of family planning procedures in western Santiago. [Resultados de una encuesta sobre planificacion familiar en al area occidental de Santiago.]
  277. Results of the use of the oral contraceptive - Ovosiston. [Rezultaty primeneniya peroralnovo kontratseptivnovo sredstva ''ovosiston.''.]
  278. Return of fertility following discontinuation of three-month contraceptive injections of DMPA plus routine oral estrogen supplement: a preliminary report.
  279. Return of menstruation and fertility in Thai women after contraceptive injections.
  280. Review of 1 year of contraception. [Bilan de un an de contraception.]
  281. The rhythm method of family planning: a programmed instruction book.
  282. Rifampicin, pregnancy, hormonal contraception, menopause and senescence. [Rifampicine, gestation, contraception hormonale, menopause et senescence.]
  283. The risk of thrombophlebitis during hormonal contraception. [Das Thrombophlebitisrisiko bei hormonaler Kontrazeption.]
  284. Risks and effectiveness of birth control methods.
  285. The role and tasks of paramedical cadres in family planning. [Uloga i zadaci srednjemedicinskih kadrova na planiranju porodice.]
  286. The role of communication in family planning.
  287. The role of extension education in family planning.
  288. Role of industrialists in family planning.
  289. The role of institutes of public administration in population and family planning programs.
  290. The role of paramedical personnel in family planning.
  291. The role of Planned Parenthood-World Population in abortion.
  292. Role of students in family planning.
  293. Role of television in promoting family planning.
  294. Role of the industrial sector in family planning.
  295. The role of the nurse in a family planning programme.
  296. The role of the physician in North Carolina family planning programs.
  297. Role of trained social workers in family planning.
  298. The roles of social workers in family planning and in developing countries - an annotated bibliography.
  299. The Roman Catholic view (on birth control)
  300. The safety of contraceptives.
  301. The safety of the oral contraceptives.
  302. Savings accounts for family planning: an illustration from the tea estates of India.
  303. Screening tests for gonorrhea in clinics for contraceptive advice. [Forekomst av gonorre hos antikonceptionssokande kvinnor.]
  304. Selected references for social workers on family planning: an annotated list. revised 1971.
  305. Self-concept and family planning.
  306. Sensibility of the ovary for gonadotropins in women with amenorrhea after oral contraception. [Ovariernas kanslighet for gonadotropiner hos kvinnor med amenorre efter oral antikonception.]
  307. Sequential oral contraception: graduated sequential therapy with Profem.
  308. Serum alpha-1 acid glycoprotein concentration in pregnancy and with oral contraception.
  309. Serum copper and zinc levels in patients taking oral contraceptives.
  310. Serum fucose levels during pregnancy and while taking oral contraceptives.
  311. Serum proteins of women utilizing combination oral or long-acting injectable progestational contraceptives.
  312. Serum-lipids in women on oral contraceptives.
  313. Severe peritonitis complicating an intrauterine contraceptive device.
  314. Sex education and family planning advice by South Dakota doctors.
  315. Sex Education and Family Planning.
  316. Sexual and medical considerations of contraception.
  317. Sexual frequency and contraceptive pills.
  318. Sexuality and contraception.
  319. The Shirodkar technique for a contraceptive vaginal hood.
  320. Should family planning clinics perform abortions?
  321. Side effects of contraceptive steroids. [Vedlejsi ucinky antikoncepcnich stereoidu.]
  322. Side effects of oral contraception. [Biverkningar vid peroral antikonception.]
  323. Simultaneous use of oral contraception and Rifampicin and other tuberculostatics. [Rifampicin und andere Antituberkulotika bei gleichzeitiger oraler Kontrazeption.]
  324. Six years experience with intrauterine contraceptive devices.
  325. Smoking, personality and oral contraception.
  326. The social and cultural context of family planning in Indonesia.
  327. Social and political considerations for family planning programme.
  328. Social aspects of family planning in India.
  329. Some aspects of family planning program cost in less developed countries.
  330. Some aspects of fertility and family planning in the urban areas of India.
  331. Some aspects on the licensing of contraceptives with special regard to the manufacture, marketing and distribution in developing countries.
  332. Some methodological problems in the investigation of rare adverse reactions to oral contraceptives.
  333. Some moral aspects of planned parenthood.
  334. Some observations on the use of the "M" intrauterine contraceptive device.
  335. Some problems in determining the number of acceptors needed in a family planning programme to achieve a specified reduction in the birth rate.
  336. Sources of family planning information for rural Thai women.
  337. Specification and analytical procedures for Neo Sampoon Loop Tablet. (vaginal contraceptive)
  338. St. Paul family planning services early demonstration project, phase 3.0 systems design.
  339. Sterilization within the framework of family planning. [Die Sterilisation im Rahmen der Familienplanung.]
  340. Sterilization: the sure method of birth control.
  341. Steroid contraceptive hormone induced ulteration in the structure of fallopian tubes.
  342. Stone-age contraception.
  343. The story of the Ernakulam Experiment in family planning.
  344. Stroke in a woman with sickle cell trait taking oral contraceptives.
  345. Strokes following intake of oral contraceptives? [Schlaganfaelle nach Einnahme von Ovulationshemmern?]
  346. Student objectives, didactic resources, and faculty models in family planning education.
  347. Studies on cervical contraception with retrosteroids. (Abstract only)
  348. Studies on the mechanism of action of a retroprogesterone in precoital contraception.
  349. A study of an indigenous drug Maswin as an oral contraceptive.
  350. A study of attitudes and knowledge in a low income population: an assessment of barriers to family planning.
  351. A study of contraceptive practices among white female college students.
  352. A study of knowledge, attitudes and practices of eligible couples of Banaskantha District towards family planning.
  353. A study of knowledge, attitudes, and practices of family planning in Uganda, East Africa.
  354. A study of mothers using oral contraceptives for family planning in an English Hospital.
  355. A study of the knowledge and attitudes of groups of Indian and Taiwanese college students towards family planning and married life.
  356. A study of the major problems of the population in Iran and the role of medical education dealing with manpower shortage in Iranian family planning programs.
  357. Study of the prescription and dispensing of contraceptive medications at institutions of higher education.
  358. Subsidized family planning services in the State of Maine: a synopsis.
  359. Summary of report on oral contraceptive pills and abnormal cervical cytology.
  360. The sure method of birth control.
  361. The surgical pathology of the reproductive system and breast during oral contraceptive therapy.
  362. A survey of family planning facilities in the Ahmedabad industrial sector.
  363. A survey of family planning facilities in the industrial concerns in Baroda.
  364. A survey of family planning in 3 industrial concerns of West Pakistan: a WPFPA KAP study.
  365. A survey of soldiers with regard to population-family planning education.
  366. A tabulation of the results of the survey on "the availability of contraceptive services and information at colleges, universities and junior colleges in the middle Atlantic region of the United States."
  367. Taiwan's finest year. (Contraception)
  368. Taiwan: appraising the effect of a family planning program through an areal analysis.
  369. Talking family planning (report of a workshop, Mombasa, Oct.-Nov. 1971)
  370. Target audiences in family planning.
  371. Targets for antienzymatic contraception. [Ansatzpunkte fuer eine antienzymatische Kontrazeption.]
  372. Teaching of human reproduction and training in family planning at medical schools: summary of a report by the IPPF Medical Education Subcommittee.
  373. Temporary sterilization of the male by an intravasal contraceptive device.
  374. A textbook for family planning field workers.
  375. Thailand: family planning activities 1968 to 1970.
  376. Therapeutic abortion, induction of labor, sterilization, and contraception.
  377. Therapeutic use of ORF 1557-.35 as a contraceptive. Preliminary note. [Utilizacao do ORF 1557-.35 em terapeutica como meio anticoncepcional. Comunicacao Preliminar.]
  378. Therapeutic use of the intrauterine contraceptive device.
  379. The things we know about family planning information.
  380. Thromboembolism after contraceptive steroids. [Tromboembolicka nemoc po antikoncepcnich steroidech.]
  381. Thromboembolism and oral contraceptive medication.

     

  382. Thromboembolism and oral contraceptives.
  383. Thromboembolism and oral contraceptives.
  384. Thrombophlebitis among oral and nonoral contraceptive users.
  385. Thrombosis during hormonal contraception in women who smoke. [Thrombosen unter hormonalen Kontrazeptiva bei Zigarettenraucherinnen.]
  386. Thrombosis of the cerebral veins and contraceptives. [Hirnvenenthrombose und Antikonzeptiva.]
  387. Thrombosis of the right internal carotid artery during continuous contraception by chlormadinone acetate in a 28-year-old woman. [Thrombose de la carotide interne droite sous traitement contraceptif continu par l'acetate de chlormadinone chez une femme de 28 ans.]
  388. Toward a framework for evaluating health education activities of a family planning program.
  389. Training course on fertility and family planning evaluation conducted in India from 2 November to 12 December 1970: an experience of value to all the developing countries.
  390. A training program for allied health personnel in family planning and cancer screening: a preliminary report.
  391. Transient cerebral ischemia and thrombosis during oral contraception. [Transitorisk cerebral iskaemi og trombose ved peroral antikonception.]
  392. Treatment of primary dysmenorrhea with a combined type oral contraceptive: a double blind study.
  393. Two cases of hepatocellular damage following the use of hormonal contraceptives. [Dwa przypadki uszkodzenia watroby po hormonalnych srodkach antykoncepcyjnych.]
  394. Two groups of university student women: sexual activity and the use of contraception.
  395. The two-phase therapy using Sequenz-Ovosiston in the framework of hormonal contraception. [Die Zweiphasentherapie mit Sequenz-Ovosiston im Rahmen der hormonalen Kontrazeption.]
  396. Uchida sterilization in family planning.
  397. The United States and family planning.
  398. Unusual focal mesenteric venous thrombosis associated with contraceptive medication: a case report.
  399. An urban family planning center: the family planning research unit, Chulalongkorn Medical School, Thailand.
  400. Urinary pregnanediol during the use of different contraceptive methods.
  401. The use of communications media in family planning programs.
  402. Use of contraception by young mothers in Copenhagen.
  403. Use of injectable contraceptive immediately post partum.
  404. The use of oral contraceptives in selective cases of mentally ill females in state hospitals.
  405. Use of oral contraceptives is affected by mass publicity on possible side effects.
  406. Use of quingestanol acetate as a contraceptive by continuous administration in small doses. [Uso del acetato de quingestanol como anticonceptivo en administracion continua a dosis bajas.]
  407. The use of radio in family planning.
  408. Use of retrospective interviews for deriving group-specific fertility patterns; evaluation of fertility reduction effectiveness of family planning programs by correlation of estimated fertility changes with estimated amounts of contraceptive practice.
  409. Use-effectiveness of oral and intrauterine contraception.
  410. Use-effectiveness of oral contraceptives by demographic characteristics.
  411. Uterine bleeding in rhesus monkeys after intrauterine contraceptive device insertion: effect of a haemostatic drug.
  412. Uterine perforation by Intrauterine contraceptive devices: diagnosis and treatment.
  413. Vaginal yeast growth and contraceptive practices.
  414. Validation of feeling, belief, and intention to act as three components of attitude and their contribution to prediction of contraceptive behavior.
  415. The value of the vital stained vaginal smear at the family planning clinic.
  416. Vascular incidents and oral contraceptives: arterial versus venous thromboembolism: a statistical study.
  417. Vasectomy as a birth control method.
  418. Vasectomy as a contraceptive method. [Die Vasektomie als Methode der Antikonzeption. Gedanken aus andrologiescher sicht.]
  419. A vasectomy service within a planned parenthood clinic.
  420. Vessel wall function in the caudal venous systems under the influence of contraceptives. An in vivo and in vitro study. [Die Gefaesswandfunktion des kaudalen Venensystems unter dem Einfluss von Kontrazeptiva. Eine In-vivo- und In-vitro-Untersuchung.]
  421. Vietnam: the first report on family planning research program.
  422. Visit continuation rates, inter visit times, and their managerial implications to family planning administrators: a case study of Atlanta.
  423. Visual fields and dark adaptation after administration of contraceptives. (Preliminary communication) [Gesichtsfeld und Dunkeladaptation nach Verabreichung von Kontrazeptiva. Vorlaufige mitteilung.]
  424. Vitamin B-6 depletion in women using oral contraceptives as determined by erythrocyte glutamic-pyruvic transaminase activities.
  425. Vitamin B-6 metabolism in users of oral contraceptive agents: 1. Abnormal urinary xanthurenic and excretion and its correction by pyridoxine.
  426. In vitro sperm migration in the human cervical mucus with different contraceptive methods.
  427. Voluntary sterilization becoming more popular as method of birth control.
  428. What else do oral contraceptives do? What are oral contraceptives? [Vad gor p-piller mera? Vad ar p-piller?]
  429. What period of a woman's life is most suitable for an effective publicity campaign on contraception? [Ve kterem obdobi zivota zeny je propagace antikoncepce nejucinnejsi?]
  430. What should we think of the Dunlop Committee's recommendation concerning oral contraceptives? [Que faut-il penser de la recommandation du Dunlop Committee concernant les pilules antiovulatoires?]
  431. What we want to know] - the administrators speak out. Opening remarks. (Family planning)
  432. Who needs organized family planning services? A preliminary projection, 1971-1975.
  433. Why do family planning patients drop out?
  434. Women and abortion: the women's abortion and contraception campaign's evidence to the Lane Commission.
  435. Women versus the Malthusian trap: the cosmetic motive for birth control.
  436. Workshop on Literacy/Population/Family Planning Education.
  437. The Ypsilon silicone covered intrauterine contraceptive device.
  438. La regolamentazione delle nascite: problema del ginecologo dal punto di vista medico, morale e religioso. (Birth control: the gynecologist's problem from the medical, moral and religious point of view)
  439. Evaluation of the results of intrauterine contraception. Two years analysis of the Rostock study using the Life Table Method of Tietze and Potter. [Bewertung der Ergebnisse der intrauterinen Kontrazeption. Zweijaresanal yse der Rostocker Studie nach der Life-table-Methode von Tietze und Potter.]
  440. Family planning and population control in developing countries.
  441. Side effects of contraceptive steroids. [Nebenwirkungen antikonzeptioneller Steroide.]
  442. Side effects of contraceptives. [Pobochnoe deistvie kontratseptivov.]
  443. Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetate.
  444. A cross-sectional study of plasma FSH and LH levels in women using sequential, combination or injectable steroid contraceptives over long periods of time.
  445. Family planning in Taiwan, Republic of China: progress and prospects.
  446. Haemodynamic changes in women taking oral contraceptives.
  447. Leibenstein on the benefits and costs of birth control programmes.
  448. Longterm contraception by subcutaneous Silastic capsules containing Megestrol Acetate.
  449. Myometrial activity and the IUCD: EFFECT OF CONTRACEPTIVE PILLS.
  450. Oral contraceptives and gestational diabetes.
  451. Oral contraceptives, hypertension and toxemia.
  452. Ovulation inhibition with a long-acting injectable contraceptive.
  453. A Program of indigent obstetric care and planned parenthood in a rural North Carolina county.
  454. A quantitative analysis of serum proteins during treatment with oral contraceptive steroids.
  455. R.C.O.G. statement on oral contraceptives.
  456. Birth control in America: the career of Margaret Sanger.
  457. Birth control in popular twentieth-century periodicals.
  458. Birth control, abortion, and venereal disease: a guide for the Boston University student.
  459. Birth control--the views of women.
  460. Birth control.
  461. Birth control. Moral, theological, medico-gynecological, and penal aspects. [Die Geburtenregelung. Moralthelogische, medizinisch-gynaekologische, und strafrechtliche Gesichtspunkte.]
  462. Births averted by contraception: an approach through renewal theory.
  463. The black family, poverty, and family planning: anthropological impressions.
  464. Blood coagulation and fibrinolysis with an injectable long-acting progestogen-oestrogen contraceptive.
  465. Blood glucose levels and glucose tolerance in prediabetic and subclinical diabetic women on a low dose progestogen contraceptive.
  466. Blood glucose levels and glucose tolerance in women with subclinical diabetes receiving an oral contraceptive.
  467. BMT 2118: a new approach to family planning.
  468. Breaking the taboo. (Birth control)
  469. Breast cancer during oral contraceptive therapy.
  470. Buccal manifestations and oral contraceptives. [Manifestations buccales et contraceptifs oraux.]
  471. Budd-Chiari syndrome and oral contraception. [Budd-Chiari-Syndrom und orale Kontrazeption.]
  472. Canadian county-sponsored family planning. III: A second survey.
  473. Carbohydrate metabolism and oral contraception. [Metabolisme hydrocarbone et contraception orale.]
  474. A case of acute myelogenic leukemia seemingly induced by intrauterine contraceptive devices.
  475. A case of thromboembolic complication following use of oral contraceptives. [Bericht uber einen Fall mit thrombembolischer Komplication unter anwendung von oralen Kontrazeptiva.]
  476. A case of thrombophlebitis in a woman on oral contraceptive.
  477. Central America and some Caribbean countries: a report on population and family planning information, education and communications programs. And problems.
  478. Cerebrovascular disease and oral contraceptives.
  479. Cerebrovascular diseases associated with the use of oral contraceptives: a review of the English-language literature.
  480. Cervical cytology and sequential birth control pills.
  481. Change in knowledge, attitude and practice of contraception during 1965-67 in Taiwan.
  482. Changes in antithrombin 3 and plasminogen induced by oral contraceptives.
  483. Changes in psychological symptoms in women taking oral contraceptives.
  484. Children, teachers and parents view birth planning. A preliminary report of The Central Family Planning Institute and Carolina Population Center Collaborative Project.
  485. China's Birth Control Action Programme, 1956-1964.
  486. Chlormadinone acetate as an oral contraceptive.
  487. Chlormadinone contraceptive withdrawn. (Letter to the editor)
  488. Chlormadinone contraceptive withdrawn. (Letter to the editor)
  489. Intracranial venous thrombosis as complication of oral contraception.
  490. Intracranial venous thrombosis complicating oral contraception.
  491. Intramuscular hormonal contraception. [Die intramuskulare hormonelle Antikonzeption.]
  492. Intrauterine and Intracervical sperm recuperation under treatment with various hormonal and intrauterine contraceptives. [Recuperacion espermatica intracervical e intrauterina bajo tratamiento con diversos anticonceptivos hormonales e intrauterinos.]
  493. Intrauterine contraception and the Armed Forces.
  494. Intrauterine contraception by using metallic ion antagonism. Presentation of a new IUD (T-Cu) [Anticoncepcion intrauterina mediante el uso de antagonismo de iones metalicos. Presentacion de un nuevo dispositivo intrauterin El T-Cu.]
  495. Intrauterine contraception in Indians of the American Southwest.
  496. Intrauterine contraception. [Die intrauterine Antikonzeption.]
  497. Intrauterine contraception. In: Social demography and medical responsibility.
  498. Intrauterine contraception: 5 years' experience. [La contraception intra-uterine: une experience de 5 ans.]
  499. The intrauterine contraceptive device and uterine perforation.
  500. Is tuberculin skin test sensitivity depressed by oral contraceptives?

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.